Sat.Mar 20, 2021 - Fri.Mar 26, 2021

article thumbnail

Life-sciences pros believe in potential of AI, blockchain: survey

Outsourcing Pharma

A survey by the Pistoia Alliance indicates most professionals believe the tech can accelerate R&D, but companies are stymied by a skills gap and data bias.

145
145
article thumbnail

Gamification for patient care, medical education, and virtual engagement

pharmaphorum

“Gamification” – adding game-like elements into non-game or real-world settings – has become a popular concept in the pharmaceutical, healthcare, and event industries, especially as virtual engagement becomes more common during COVID-19. However, it is proving more than a mere buzzword. With diverse applications and approaches, it is quickly becoming a promising tool for patient adherence, chronic disease management, preventive medicine, rehabilitation, and paediatric care, as well as for medica

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cancer Research UK launches new ‘cancer tech accelerator’ programme

Pharma Times

New initiative aims to help researchers translate their ideas into innovations for cancer patients

137
137
article thumbnail

AstraZeneca’s Covid-19 Vaccine Found to Be 79% Effective in U.S. Study

NY Times

The vaccine maker is preparing to apply for emergency authorization from the Food and Drug Administration. But the vaccine may not be needed in the United States.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

MedVector introduces patient enrollment expansion solution

Outsourcing Pharma

The companyâs Prime-Control Technology is designed to help study teams expand their subject enrollment beyond the reach of their clinical trial sites.

98
article thumbnail

Novartis’ radioligand therapy meets phase 3 prostate cancer trial target

pharmaphorum

Novartis’ radioligand therapy Lu-PSMA-617 has met its target in prostate cancer, as its $2.1 billion acquisition of specialist pharma Endocyte looks to have been justified. . The big Swiss pharma added this drug to its pipeline after it swooped for Endocyte and so far it looks like a good piece of business, with potential blockbuster sales predicted for the drug if it makes it to market.

More Trending

article thumbnail

Which pharmaceutical drugs have the most drug patents in Bulgaria?

Drug Patent Watch

This chart shows the drugs with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Bulgaria? appeared first on DrugPatentWatch - Make Better Decisions.

94
article thumbnail

Cancer research benefits from harnessing real-world data

Outsourcing Pharma

A leader from oncologist-founded trial tech specialists COTA shares how advanced data analysis can benefit cancer researchers and patients alike.

98
article thumbnail

Boris Johnson slammed for saying “greed” is behind UK vaccine success

pharmaphorum

Boris Johnson’s sense of humour seems to have got him into trouble again, at the most delicate of times. The Prime Minister reportedly told Conservative backbench MPs on a Zoom call that “capitalism” and “greed” was behind the success of the UK’s COVID-19 vaccination programme, before backtracking after realising he had made a blunder and telling attendees to forget the comments.

Vaccines 124
article thumbnail

EMA accepts Astellas/Seagen’s enfortumab vedotin for review

Pharma Times

Marketing authorisation application is seeking approval for advanced urothelial cancer

123
123
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Which drugs have supplementary protection certificates in the most countries?

Drug Patent Watch

This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…. The post Which drugs have supplementary protection certificates in the most countries? appeared first on DrugPatentWatch - Make Better Decisions.

90
article thumbnail

Digital Tools at the Center of Healthcare Digitalization

Pharma Marketing Network

Innovation During COVID-19 Fact Sheet. We compiled a fact sheet on innovations in digital publishing that sparked due to the pandemic and have since been soaring. . Get your complimentary copy of "The Publishing Industry: The Soar of Innovation During COVID-19 Fact Sheet". Name *. First. Last. Company Email *. Lead Source * Web Active Prospecting Sales Ad-Label Advertising - Offline Advertising - Online Advertising - Online - FocalPoint Advertising - Online - Mobile Advertising - Online - Trend

article thumbnail

The Brexit deal; shot in the arm or kick in the teeth for the pharma sector?

pharmaphorum

The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. While pharma companies grapple with the effects of Brexit, there are undoubtedly a number of ways that the TCA benefits the sector, while leaving significant issues unanswered.

article thumbnail

Cambridge start-up PhoreMost raises £33m to progress PLK1 programme

Pharma Times

Lead ‘Allosteric PLK1’ asset will initially target brain cancer

123
123
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Which pharmaceutical companies have the most SPCs in France?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in France. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in France? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Online health communities connect patients, trial teams

Outsourcing Pharma

Health Union offers patients dealing with a range of conditions ways to connect with valuable information, research opportunities and each other online.

72
article thumbnail

AI drug discovery player 1910 Genetics debuts with $26m war chest

pharmaphorum

There’s a new kid on the block among companies using artificial intelligence in drug discovery, after 1910 Genetics launched today with $26 million in financing. The Cambridge, Massachusetts-based startup claims it is the only biotech launched so far that will use AI to design both small-molecule drugs and protein therapeutics, coupled with automated biological testing to speed up drug development and reduce costs.

article thumbnail

Relugolix shows potential long-term benefit in women with uterine fibroids

Pharma Times

Study compared women who continued on relugolix combination therapy with women who discontinued treatment

123
123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New patent for Cubist Pharms drug ZERBAXA

Drug Patent Watch

Annual Drug Patent Expirations for ZERBAXA Zerbaxa is a drug marketed by Cubist Pharms Llc and is included in one NDA. It is available from one supplier. There are twelve…. The post New patent for Cubist Pharms drug ZERBAXA appeared first on DrugPatentWatch - Make Better Decisions.

57
article thumbnail

IQVIA expands reach of its decentralized trial solutions

Outsourcing Pharma

The company reports that its patient-centric virtual study technology currently is in use in more than 60 ongoing trials in over 40 different countries.

72
article thumbnail

Solving the “information challenge” of rare disease diagnosis

pharmaphorum

Getting a diagnosis is often the biggest challenge facing a rare disease patient in the UK. We take a look at efforts from charities, the government and digital innovators to boost awareness of rare conditions among GPs and make the clinical pathway smoother for patients. There are more than 150,000 people living with a rare neurological condition in the UK, which taken together means that these conditions aren’t actually that rare at all – and that’s just for one slice of the wider rare disease

105
105
article thumbnail

Report urges pharma companies to utilise synthetic data in clinical trials

Pharma Times

Report outlines two cases for using synthetic data in the clinical trial process

123
123
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Which pharmaceutical companies have the most drug patents in United Kingdom?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in United Kingdom. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical companies have the most drug patents in United Kingdom? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Collecting patient data challenging in evolving trial landscape

Outsourcing Pharma

Two experts from CRO Phastar talk about how trial professionals face new, ever-changing challenges regarding collecting and disseminating patient data.

59
article thumbnail

Doubts emerge over AZ’s ‘outdated’ US vaccine trial data

pharmaphorum

AstraZeneca has been rebuked by a US health authority after a trial monitoring board said data published from a large study of its COVID-19 vaccine may be out of date and may not give a representative view of its efficacy. The company’s share price ticked down after the statement on Monday from the US National Institute for Allergy and Infectious Diseases (NIAID).

article thumbnail

Roche’s Tecentriq improves disease-free survival in early lung cancer

Pharma Times

Tecentriq is approved in five lung cancer indications currently

123
123
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

How to Achieve and Maintain a Nice Smile

Pharma Mirror

One of the best gifts you can give to another person is a beautiful smile. Though it costs you nothing, it goes a long way in adding to others and you. It typically has a favourable effect on others, attracts people to you, and makes you approachable and likeable. A smile is very important. It is a part of your dressing and personality. Without a smile, you are incomplete, no matter how expensively and gorgeously dressed you are.

52
article thumbnail

Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies

Outsourcing Pharma

A US courtâs recent decision to find in favor of Sanofi and invalidate Amgen's broad antibody patent claims has biotech manufacturers concerned about how to preserve their IP.

56
article thumbnail

Roche stops dosing in trial of Huntington’s disease hopeful tominersen

pharmaphorum

Roche has stopped dosing in a phase 3 trial of tominersen, a potential Huntington’s disease (HD) drug developed with Ionis, after a pre-planned review by independent experts. . The companies had been working on tominersen since December 2017, when Roche licensed it in from Ionis. There were high expectations for tominersen, which the companies hoped would be the first drug to treat the underlying cause of the disease, which leads to devastating neurological degeneration.

article thumbnail

‘Formal review’ of GP access arrangements needed, says Healthwatch

Pharma Times

UK-based charity conducted a review of GP access between April 2019 and December 2020

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.